Τρίτη 24 Μαΐου 2022

Maternal and Neonatal SARS-CoV-2 Omicron Variant Neutralization after Antenatal mRNA Vaccination

alexandrossfakianakis shared this article with you from Inoreader
Abstract
We evaluated the neutralization efficiency against SARS-CoV-2 omicron variant in maternal and cord blood sera after antenatal BNT162b2 vaccination. Neutralizing antibodies against omicron were lacking at the time of delivery after two-dose vaccination. A third booster dose was essential in building neutralizing antibody capacity against omicron among mothers and neonates.
View on Web

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου